Event Type
Disclosure
Mandatory
Variant
8-K
Submission of Matters to a Vote of Security Holders On December 1, 2025, Integrated BioPharma, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders
Financial Statements and Exhibits. (d) Exhibits. The following exhibit relating to Item 5.07 shall be deemed to be furnished, and not filed: 104 Cover Page Inte